Capitalizing on Opportunities to Drive Impact in Commercial Operations

Throughout the first half of 2022, we’ve continued to face historic, unprecedented challenges related to the ongoing global pandemic. Life sciences enterprises, and essentially all industries, are grappling with decisions large and small. Priorities for Commercial, Market Access and Medical Affairs organizations in the life sciences industry continue to shift as teams work feverishly to evolve virtual and digital channels to engage with customers, and to sharpen Advanced Analytics. Developing capabilities and skills in new ways of working continue in the forefront of strategic priorities, along with increasing challenges in securing and retaining the right talent. Challenges related to vaccinations, variants, and decisions on returning to the office have seemed like a roller coaster.  

Every day, our member companies reach out to TGaS Advisors for guidance in navigating this uncharted territory, and we proactively support more than 2,000 individuals across 300 partner companies. The findings in this Advisory Brief are based on our work with these companies and relate to key themes that emerged during our 2022 Spring Virtual Client Summit.

Complete the form below to access the full brief

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.